PapersFlow Research Brief

Health Sciences · Medicine

Sex and Gender in Healthcare
Research Guide

What is Sex and Gender in Healthcare?

Sex and Gender in Healthcare is the study of biological sex differences and sociocultural gender influences on health outcomes, disease pathophysiology, treatment responses, and healthcare delivery, with a focus on addressing biases in biomedical research and clinical practice.

This field encompasses 34,915 works that examine pervasive gender bias in biomedical research, particularly in neuroscience, clinical trials, and cardiovascular disease. Key areas include sex differences in immune responses and the impact of gender norms on health outcomes. Research highlights the need for sex-specific analyses and gender equity to improve public health.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Public Health, Environmental and Occupational Health"] T["Sex and Gender in Healthcare"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
34.9K
Papers
N/A
5yr Growth
239.9K
Total Citations

Research Sub-Topics

Why It Matters

Sex and gender considerations in healthcare directly affect treatment efficacy and patient outcomes across major diseases. For instance, "Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women" by Hulley (1998) found that estrogen plus progestin did not reduce coronary heart disease events over 4.1 years but increased thromboembolic events, influencing guidelines against routine hormone therapy for cardiovascular prevention in postmenopausal women. Similarly, "The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization" by Schulman et al. (1999) showed that physicians recommended cardiac catheterization less often for women and Black patients with chest pain, revealing biases that contribute to health inequalities. In diabetes, "Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus" by Kautzky-Willer et al. (2016) demonstrated that type 2 diabetes is diagnosed at lower age and BMI in men, while obesity poses a greater risk in women, guiding sex-tailored management strategies. These findings underscore applications in clinical trials, endocrinology, and public health to reduce disparities.

Reading Guide

Where to Start

"Sex differences in immune responses" by Klein and Flanagan (2016) serves as the starting point for beginners because it provides a foundational review of biological mechanisms across diseases, accessible yet comprehensive for understanding core sex differences.

Key Papers Explained

Klein and Flanagan (2016) establish sex differences in immune responses, which connect to cardiovascular papers like Hulley (1998) and Manson et al. (2003) that reveal hormone therapy failures in women, highlighting sex-specific treatment risks. Schulman et al. (1999) builds on these by showing physician biases in cardiac care, while Kautzky-Willer et al. (2016) extends to diabetes pathophysiology; Hembree et al. (2017) addresses gender-affirming care, and Bowleg (2012) integrates intersectionality across all.

Paper Timeline

100%
graph LR P0["Randomized Trial of Estrogen Plu...
1998 · 6.2K cites"] P1["Estrogen plus Progestin and the ...
2003 · 2.0K cites"] P2["Effectiveness-Based Guidelines f...
2011 · 2.1K cites"] P3["The Problem With the Phrase W...
2012 · 2.7K cites"] P4["International Statistical Cla...
2014 · 3.6K cites"] P5["Sex differences in immune responses
2016 · 5.9K cites"] P6["Endocrine Treatment of Gender-Dy...
2017 · 2.1K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P0 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Current frontiers emphasize implementing sex- and gender-specific analyses in ongoing clinical trials and public health interventions, as evidenced by persistent biases noted in top-cited works like Schulman et al. (1999) and evolving guidelines in Hembree et al. (2017).

Papers at a Glance

Frequently Asked Questions

What are sex differences in immune responses?

Sex differences in immune responses arise from genetic, hormonal, and environmental factors that lead to distinct immune profiles between males and females. Klein and Flanagan (2016) detail how these differences affect vaccine efficacy and disease susceptibility. Females often mount stronger antibody responses but face higher autoimmune disease rates.

How does hormone therapy impact cardiovascular risk in postmenopausal women?

Hormone therapy with estrogen plus progestin does not reduce coronary heart disease risk and may increase events like thromboembolism. Hulley (1998) reported no overall CHD event reduction over 4.1 years, while Grady et al. (2002) confirmed no risk reduction after 6.8 years in women with CHD. These trials advise against using postmenopausal hormone therapy for cardiovascular prevention.

What is intersectionality in public health?

Intersectionality posits that social categories like race, gender, and socioeconomic status intersect to shape health experiences through interlocking systems of privilege and oppression. Bowleg (2012) argues that phrases like 'women and minorities' overlook these overlaps. This framework aids in analyzing compounded health disparities.

How do sex and gender affect type 2 diabetes?

Sex and gender differences influence type 2 diabetes risk, pathophysiology, and complications, with men diagnosed at lower BMI and younger age. Kautzky-Willer et al. (2016) note obesity as a stronger risk factor in women. These variations necessitate sex-specific screening and treatment approaches.

What biases affect physicians' cardiac recommendations?

Physicians' recommendations for cardiac catheterization are influenced by patient race and sex independently. Schulman et al. (1999) found lower referral rates for women and Black patients with chest pain. This demonstrates how biases impact management of cardiovascular conditions.

What guidelines exist for endocrine treatment of gender-dysphoric persons?

The Endocrine Society provides clinical practice guidelines for hormone therapy in gender-dysphoric persons, updating prior recommendations. Hembree et al. (2017) outline objectives, participant criteria, and evidence-based protocols. These support safe, effective gender-affirming care.

Open Research Questions

  • ? How can intersectional frameworks better integrate sex, gender, race, and socioeconomic status in clinical trial designs?
  • ? What mechanisms underlie sex-specific immune responses and their implications for vaccine development?
  • ? Why do hormone therapies show no cardiovascular benefit and increased risks in certain postmenopausal populations?
  • ? In what ways do physician biases based on patient sex and race persist in modern diagnostic recommendations?
  • ? How do sex differences in type 2 diabetes pathophysiology inform personalized prevention strategies?

Research Sex and Gender in Healthcare with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Sex and Gender in Healthcare with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers

Curated by PapersFlow Research Team · Last updated: February 2026

Academic data sourced from OpenAlex, an open catalog of 474M+ scholarly works · Web insights powered by Exa Search

Editorial summaries on this page were generated with AI assistance and reviewed for accuracy against the source data. Paper metadata, citation counts, and publication statistics come directly from OpenAlex. All cited papers link to their original sources.